Pharmacology Review for NURS 5334
Final Exam
1. Drugs combined with Hydrocodone: Aspirin, Acetaminophen,
Ibuprofen
2. Benzodiazepines and CNS depressants with
acetaminophen-hydrocodone-
: False, this could lead to respiratory depression
3. Buprenorphine for maintenance after opioid abuse: Partial
opioid agonist that activated opioid receptors but produces less
degree of euphoria and physical dependence compared to a full
agonist
4. Naltrexone for maintenance after opioid abuse: Naltrexone
is a opioid antag- onist that blocks the euphoric and sedative
effects of opioids.
5. Side effects of Hydrocodone: Constipation, Respiratory
depression, Addiction
6. MOA of Sumatriptan: Selective agonist for serotonin 5HT
receptors on intracra- nial blood vessels and sensory nerves of the
trigeminal system, causes VASOCON- STRICTION and reduces
neurogenic inflammation
7. Feverfew use: Migraine Prophylaxis
,8. Drugs that cannot be combined with Feverfew: Antiplatlets,
Anticoagulants, Increased risk of bleeding in patients taking
antiplatelets (Aspirin) and anticoagu- lants (Warfarin)
9. Folic acid for Folic Acid Deficiency: Give 1-2mg/day PO for a
deficiency
10. Folic acid for women of childbearing age: 400-800 mcg daily
11. Folic acid for pregnant women: 400-600 mcg/day
12. Tacrolimus and Pimecrolimus cream use: Atopic Dermatitis
(Eczema)
13. Safe drug classes in later pregnancy: Beta blockers
14. Safe medications for pregnant women: Methyldopa and
Labetalol are the traditional agents of choice for pregnant women
15. Methyldopa and Labetalol use in pregnancy: These drugs
have limited effects on uteroplacental and fetal hemodynamics and
do not adversely affect the fetus or neonate
16. Anticholinergics for drooling in Parkinson's: True
17. Medication for COPD with eosinophils 312: Salmeterol +
aclidinium + Budes- onide
18. COPD Group A: Bronchodilator
19. COPD Group B: LABA + LAMA
20. COPD Group E: LABA + LAMA
, 21. Body fat percentage effect on lipid soluble drugs: The
higher the body fat percentage the more the plasma levels of lipid
soluble drugs will be reduced
22. Lean mass decrease effect on water soluble drugs:
Increased
23. Malnourished elderly patients and protein binding drugs:
Increase
24. Proquad Vaccine education: Deposited getting the vaccine
there is still a chance your child could get breakthrough
chickenpox
25. Starting dosage of thyroid medication for 51-year-old: 50
mcg
26. Starting dosage of thyroid medication for 68-year-old: 25
mcg
27. Dosage range for thyroid medication with CAD: 12-25 mcg
28. Attenuated vaccine definition: Live Virus, but weakened
29. Immunocompromised patients and Attenuated Vaccines:
False, live vac- cines can be dangerous in recipients who are
immunocompromised because these people are unable to mount
an effective immune response, even against a virulent organism
30. TDap vaccine administration window for pregnant
women: 29 - 36 weeks
Final Exam
1. Drugs combined with Hydrocodone: Aspirin, Acetaminophen,
Ibuprofen
2. Benzodiazepines and CNS depressants with
acetaminophen-hydrocodone-
: False, this could lead to respiratory depression
3. Buprenorphine for maintenance after opioid abuse: Partial
opioid agonist that activated opioid receptors but produces less
degree of euphoria and physical dependence compared to a full
agonist
4. Naltrexone for maintenance after opioid abuse: Naltrexone
is a opioid antag- onist that blocks the euphoric and sedative
effects of opioids.
5. Side effects of Hydrocodone: Constipation, Respiratory
depression, Addiction
6. MOA of Sumatriptan: Selective agonist for serotonin 5HT
receptors on intracra- nial blood vessels and sensory nerves of the
trigeminal system, causes VASOCON- STRICTION and reduces
neurogenic inflammation
7. Feverfew use: Migraine Prophylaxis
,8. Drugs that cannot be combined with Feverfew: Antiplatlets,
Anticoagulants, Increased risk of bleeding in patients taking
antiplatelets (Aspirin) and anticoagu- lants (Warfarin)
9. Folic acid for Folic Acid Deficiency: Give 1-2mg/day PO for a
deficiency
10. Folic acid for women of childbearing age: 400-800 mcg daily
11. Folic acid for pregnant women: 400-600 mcg/day
12. Tacrolimus and Pimecrolimus cream use: Atopic Dermatitis
(Eczema)
13. Safe drug classes in later pregnancy: Beta blockers
14. Safe medications for pregnant women: Methyldopa and
Labetalol are the traditional agents of choice for pregnant women
15. Methyldopa and Labetalol use in pregnancy: These drugs
have limited effects on uteroplacental and fetal hemodynamics and
do not adversely affect the fetus or neonate
16. Anticholinergics for drooling in Parkinson's: True
17. Medication for COPD with eosinophils 312: Salmeterol +
aclidinium + Budes- onide
18. COPD Group A: Bronchodilator
19. COPD Group B: LABA + LAMA
20. COPD Group E: LABA + LAMA
, 21. Body fat percentage effect on lipid soluble drugs: The
higher the body fat percentage the more the plasma levels of lipid
soluble drugs will be reduced
22. Lean mass decrease effect on water soluble drugs:
Increased
23. Malnourished elderly patients and protein binding drugs:
Increase
24. Proquad Vaccine education: Deposited getting the vaccine
there is still a chance your child could get breakthrough
chickenpox
25. Starting dosage of thyroid medication for 51-year-old: 50
mcg
26. Starting dosage of thyroid medication for 68-year-old: 25
mcg
27. Dosage range for thyroid medication with CAD: 12-25 mcg
28. Attenuated vaccine definition: Live Virus, but weakened
29. Immunocompromised patients and Attenuated Vaccines:
False, live vac- cines can be dangerous in recipients who are
immunocompromised because these people are unable to mount
an effective immune response, even against a virulent organism
30. TDap vaccine administration window for pregnant
women: 29 - 36 weeks
